Company: GammaDelta Therapeutics
Job title: VP of Research
Alice Brown is Vice President of Research at GammaDelta Therapeutics leading an R&D team developing Vd1 gd T cells as a novel cell therapy approach for tackling solid tumours and hematologic malignancies. Prior to GammaDelta, Alice spent 7 years with the oncolytic virus company, PsiOxus Therapeutics, as Director of Biology. Alice has a PhD in Biochemistry and carried out her post-doctoral research in Prof. Dan Davis’ Lab at Imperial College London studying the basic biology and interactions of human NK cells.